TY - JOUR
T1 - Abnormal morphology of fibrillin microfibrils in fibroblast cultures from patients with neonatal Marfan syndrome
AU - Godfrey, M.
AU - Raghunath, M.
AU - Cisler, J.
AU - Bevins, C. L.
AU - DePaepe, A.
AU - Di Rocco, M.
AU - Gregoritch, J.
AU - Imaizumi, K.
AU - Kaplan, P.
AU - Kuroki, Y.
AU - Silberbach, M.
AU - Superti-Furga, A.
AU - Van Thienen, M. N.
AU - Vetter, U.
AU - Steinmann, B.
PY - 1995
Y1 - 1995
N2 - The Marfan syndrome (MFS) is a connective tissue disorder manifested by variable and pleiotropic features in the skeletal, ocular, and cardiovascular systems. The average life span in MFS is about 35 years. A group with much more severe cardiovascular disease and a mean life span of approximately 1 year also exists. We refer to this latter group as 'neonatal Marfan syndrome' (nMFS). Fibrillin defects are now known to be the cause of MFS and nMFS. Immunofluorescence studies were the first to demonstrate this association. Here we describe immunofluorescence studies in a series of 10 neonates and summarize their salient clinical features. In vitro accumulation of fibrillin reactive fibers was assayed using monoclonal antibodies to fibrillin in hyperconfluent fibroblast cultures. As was previously observed in MFS, fibroblast cultures from nMFS patients showed an apparent decrease in accumulation of immunostainable fibrillin. Significantly, however, the morphology of the immunostained fibrils in the nMFS cultures were abnormal and differed not only from control cultures, but also from those seen in cultures of MFS fibroblasts. The nMFS fibrils appeared short, fragmented, and frayed, characteristics that are not seen in MFS. Both the clinical and fibrillin morphology data provide evidence to suggest a useful subclassification of nMFS in the spectrum of MFS.
AB - The Marfan syndrome (MFS) is a connective tissue disorder manifested by variable and pleiotropic features in the skeletal, ocular, and cardiovascular systems. The average life span in MFS is about 35 years. A group with much more severe cardiovascular disease and a mean life span of approximately 1 year also exists. We refer to this latter group as 'neonatal Marfan syndrome' (nMFS). Fibrillin defects are now known to be the cause of MFS and nMFS. Immunofluorescence studies were the first to demonstrate this association. Here we describe immunofluorescence studies in a series of 10 neonates and summarize their salient clinical features. In vitro accumulation of fibrillin reactive fibers was assayed using monoclonal antibodies to fibrillin in hyperconfluent fibroblast cultures. As was previously observed in MFS, fibroblast cultures from nMFS patients showed an apparent decrease in accumulation of immunostainable fibrillin. Significantly, however, the morphology of the immunostained fibrils in the nMFS cultures were abnormal and differed not only from control cultures, but also from those seen in cultures of MFS fibroblasts. The nMFS fibrils appeared short, fragmented, and frayed, characteristics that are not seen in MFS. Both the clinical and fibrillin morphology data provide evidence to suggest a useful subclassification of nMFS in the spectrum of MFS.
UR - http://www.scopus.com/inward/record.url?scp=0028999786&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028999786&partnerID=8YFLogxK
M3 - Article
C2 - 7778680
AN - SCOPUS:0028999786
SN - 0002-9440
VL - 146
SP - 1414
EP - 1421
JO - American Journal of Pathology
JF - American Journal of Pathology
IS - 6
ER -